Langerhans cells in squamous cell carcinoma vs. pseudoepitheliomatous hyperplasia of the skin

J Cutan Pathol. 2007 Dec;34(12):950-2. doi: 10.1111/j.1600-0560.2007.00741.x.

Abstract

Background: In clinical and histopathological practice, it is sometimes difficult to distinguish pseudoepitheliomatous hyperplasia (PEH) from squamous cell carcinoma (SCC) of the skin. Several studies have shown a low density of Langerhans cells in SCC of the skin, and recent research on cervical SCCs has suggested that the decreased density of dendritic cells is secondary to low E-cadherin expression. SCCs of the head and neck similarly have decreased E-cadherin expression, but E-cadherin expression is preserved in PEH. We hypothesized that PEH of the skin would have an increased number of Langerhans cells compared with SCC.

Methods: We studied immunohistochemical expression of CD1a on paraffin-embedded tissue in 12 cases of SCC and 11 cases of PEH of the skin.

Results: The number of Langerhans cells in SCCs vs. PEH was similar; in both types of lesions, the Langerhans cells were decreased in density compared with the normal flanking epidermis.

Conclusions: PEH has a decreased number of Langerhans cells compared with the normal epidermis. As SCCs also have decreased numbers of CD1a-positive cells, this stain is not useful in differentiating these two entities.

MeSH terms

  • Antigens, CD1 / metabolism*
  • Carcinoma, Squamous Cell / pathology*
  • Diagnosis, Differential
  • Humans
  • Hyperplasia
  • Immunohistochemistry
  • Langerhans Cells / metabolism*
  • Skin / pathology*
  • Skin Neoplasms / pathology*

Substances

  • Antigens, CD1
  • CD1a antigen